Mr Sanjeev Bhatt, Senior Vice President of Corporate Strategy at Meril Life Sciences
“The Union Budget 2025-26 reflects a bold and visionary commitment to strengthening India’s healthcare ecosystem. The substantial investment in infrastructure, medical education, and AI-driven diagnostics will not only enhance accessibility but also position India as a global leader in healthcare innovation. The exemption of Basic Customs Duty on lifesaving drugs is a transformative step towards affordability for patients battling critical illnesses. As we work towards bridging the urban-rural healthcare divide, these strategic initiatives will pave the way for a healthier, more resilient nation. We welcome this progressive budget and look forward to collaborating with the government to drive meaningful advancements in the sector”.
